Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Teofili

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
British Journal of Haematology|August 1, 1990
Type II oestrogen binding sites in acute lymphoid and myeloid leukaemias: growth inhibitory effect of oestrogen and flavonoidsL M Larocca, M Piantelli, G Leone, et al.
Leukemia Research|January 1, 1992
The combination of quercetin and cytosine arabinoside synergistically inhibits leukemic cell growthL Teofili, L Pierelli, M S Iovino, et al.
Leukemia|May 10, 2017
RNA editing signature during myeloid leukemia cell differentiationC Rossetti, E Picardi, M Ye, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2000
MiCMA: an alternative treatment for refractory or recurrent Hodgkin's diseaseE O La Barbera, P Chiusolo, L Laurenti, et al.
Cancer|January 21, 2000
Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin diseaseM Aglietta, F Montemurro, F Fagioli, et al.
International Journal of Cancer|October 23, 1997
Differential sensitivity of leukemic and normal hematopoietic progenitors to the killing effect of hyperthermia and quercetin used in combination: role of heat-shock protein-70L M Larocca, F O Ranelletti, N Maggiano, et al.
Blood|February 13, 2001
Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin diseaseL Teofili, A L Di Febo, F Pierconti, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
British Journal of Haematology|August 1, 1990
Type II oestrogen binding sites in acute lymphoid and myeloid leukaemias: growth inhibitory effect of oestrogen and flavonoidsL M Larocca, M Piantelli, G Leone, et al.
Leukemia Research|January 1, 1992
The combination of quercetin and cytosine arabinoside synergistically inhibits leukemic cell growthL Teofili, L Pierelli, M S Iovino, et al.
Leukemia|May 10, 2017
RNA editing signature during myeloid leukemia cell differentiationC Rossetti, E Picardi, M Ye, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2000
MiCMA: an alternative treatment for refractory or recurrent Hodgkin's diseaseE O La Barbera, P Chiusolo, L Laurenti, et al.
Cancer|January 21, 2000
Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin diseaseM Aglietta, F Montemurro, F Fagioli, et al.
International Journal of Cancer|October 23, 1997
Differential sensitivity of leukemic and normal hematopoietic progenitors to the killing effect of hyperthermia and quercetin used in combination: role of heat-shock protein-70L M Larocca, F O Ranelletti, N Maggiano, et al.
Blood|February 13, 2001
Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin diseaseL Teofili, A L Di Febo, F Pierconti, et al.
Pageof 5